MedPath

Succinylcholine Chloride

These highlights do not include all the information needed to use succinylcholine chloride injection safely and effectively. See full prescribing information for succinylcholine chloride injection. Succinylcholine chloride injection injection, for intravenous or intramuscular use. Initial U.S. Approval: 1952

Approved
Approval ID

b336b8e5-f795-ee89-e053-2a95a90a6bbe

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 17, 2022

Manufacturers
FDA

STI Pharma LLC

DUNS: 832714070

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Succinylcholine Chloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54879-037
Application NumberANDA214308
Product Classification
M
Marketing Category
C73584
G
Generic Name
Succinylcholine Chloride
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateNovember 17, 2022
FDA Product Classification

INGREDIENTS (6)

SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SUCCINYLCHOLINE CHLORIDEActive
Quantity: 20 mg in 1 mL
Code: I9L0DDD30I
Classification: ACTIB
METHYLPARABENInactive
Quantity: 1.8 mg in 1 mL
Code: A2I8C7HI9T
Classification: IACT
PROPYLPARABENInactive
Quantity: 0.2 mg in 1 mL
Code: Z8IX2SC1OH
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Succinylcholine Chloride - FDA Drug Approval Details